戻る Agenda
Session 1: Keynote Address
Session Chair(s)
Marc Poitras, PhD, MBA
Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
Health Canada, Canada
There are a myriad of regulatory changes in the works and in the wings, from Patented Medicine pricing reviews, new collaborations with HTA reviewers and other regulators, to review and approval process improvements. While both exciting and at times maybe frightening, these changes should ultimately ease our access to innovative medicines. Hear from a key stakeholder in the telecommunications industry (also heavily regulated) about his experience, lessons learned, and how to keep your focus on the right outcomes.
Speaker(s)
Panelist
Karen Feltmate
Redstone Health Group, Inc., Canada
President
Working Through Regulatory Transformation: Lessons Learned From a Related Industry
Robert Ghiz
Canadian Wireless Telecommunications Association, Canada
President and CEO
Panelists:
Pierre Sabourin, MBA
Health Canada, Canada
Assistant Deputy Minister, Health Products and Food Branch